B+
Bull case
25%
Probability
Target price
$2.80
Analysis reference price unavailable
Analysis 2026-10-11 · RankAlpha Sentiment Codex
CCLD
CareCloudANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$1.90
Analysis reference price unavailable
Analysis 2026-10-11 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$1.20
Analysis reference price unavailable
Analysis 2026-10-11 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-10-11
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+69.5
Score
AI commentary
Cautious monitoring view. The company reported revenue growth and reaffirmed guidance, but Q2 earnings weakened and the second-half profit hurdle is demanding [#SEC-8K-2026-08-06]. Reliable post-results price reaction, analyst revisions, options skew, short interest, employee sentiment, and sufficient social coverage are unavailable. Zero-valued sentiment fields denote missing data, not neutral measurements.
RankAlpha Sentiment Codex - 2026-10-11
Open full AI memoEvidence flagged
Coverage is limited for this name. This memo is usable, but confidence is lower and evidence depth is thinner than a standard report.
Impact
tentative
Confidence
-
AI events
2026-12-31eventSecond-half profitability testHigh impact
CareCloud reaffirmed 2026 revenue guidance of $128–$132 million and adjusted EBITDA guidance of $29–$31 million. With first-half adjusted EBITDA of $11.3 million, it needs $17.7–$19.7 million in the second half to meet the EBITDA range. Execution against that ramp is the central test [#SEC-8K-2026-08-06].
2027-06-30catalystEmpower cross-sell and AI investment returnsHigh impact
The Empower acquisition added compliance and audit-defense services that CareCloud intends to cross-sell to its provider network. Management also cited increased AI-related R&D spending; the resulting revenue and margin benefits remain unproven [#SEC-8K-2026-08-06].
Recommendation
N/A
No formal recommendation provided.
As of 2026-10-11 • Updated nightlySource: Internal modelMethodology